HSPA9 Human (+)-schisandrin B increases expression ISO Hspa9 (Rattus norvegicus) 6480464 schizandrin B results in increased expression of HSPA9 protein CTD PMID:21616119 HSPA9 Human (+)-schisandrin B multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA9 mRNA] CTD PMID:31150632 HSPA9 Human (-)-anisomycin multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 Anisomycin inhibits the reaction [Cocaine results in increased expression of HSPA9 protein] CTD PMID:12422371 HSPA9 Human (1->4)-beta-D-glucan multiple interactions ISO Hspa9 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HSPA9 mRNA CTD PMID:36331819 HSPA9 Human (25R)-cholest-5-ene-3beta,26-diol increases expression EXP 6480464 27-hydroxycholesterol results in increased expression of HSPA9 protein CTD PMID:33880675 HSPA9 Human (25R)-cholest-5-ene-3beta,26-diol multiple interactions EXP 6480464 CAT protein inhibits the reaction [27-hydroxycholesterol results in increased expression of HSPA9 protein] more ... CTD PMID:33880675 HSPA9 Human (R)-adrenaline multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of HSPA9 protein CTD PMID:19464573 HSPA9 Human 1,2-dimethylhydrazine multiple interactions ISO Hspa9 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of HSPA9 mRNA] CTD PMID:22206623 HSPA9 Human 1,2-dimethylhydrazine increases expression ISO Hspa9 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of HSPA9 mRNA CTD PMID:22206623 HSPA9 Human 1-naphthyl isothiocyanate increases expression ISO Hspa9 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of HSPA9 mRNA CTD PMID:20551477 HSPA9 Human 1-naphthyl isothiocyanate multiple interactions EXP 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of HSPA9 mRNA CTD PMID:27344345 HSPA9 Human 17alpha-ethynylestradiol increases expression ISO Hspa9 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of HSPA9 mRNA CTD PMID:17942748 HSPA9 Human 17alpha-ethynylestradiol multiple interactions ISO Hspa9 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HSPA9 mRNA CTD PMID:17942748 HSPA9 Human 17beta-estradiol decreases expression ISO Hspa9 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of HSPA9 mRNA CTD PMID:32145629 HSPA9 Human 1H-pyrazole increases expression ISO Hspa9 (Mus musculus) 6480464 pyrazole results in increased expression of HSPA9 mRNA CTD PMID:17945193 HSPA9 Human 2,2,2-tetramine multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 Trientine inhibits the reaction [Streptozocin results in decreased expression of HSPA9 protein] CTD PMID:19634143 HSPA9 Human 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO Hspa9 (Mus musculus) 6480464 2 more ... CTD PMID:31388691 HSPA9 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSPA9 mRNA CTD PMID:16039398 HSPA9 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Hspa9 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSPA9 mRNA CTD PMID:20959002 HSPA9 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of HSPA9 mRNA CTD PMID:22574217 HSPA9 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Hspa9 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of HSPA9 mRNA CTD PMID:21570461 HSPA9 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Hspa9 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of HSPA9 mRNA CTD PMID:17942748 and PMID:21041162 HSPA9 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Hspa9 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HSPA9 mRNA CTD PMID:17942748 HSPA9 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Hspa9 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of HSPA9 mRNA CTD PMID:20159946 HSPA9 Human 2,4,6-tribromophenol decreases expression EXP 6480464 2 more ... CTD PMID:31675489 HSPA9 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO Hspa9 (Mus musculus) 6480464 2 more ... CTD PMID:16451863 HSPA9 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO Hspa9 (Mus musculus) 6480464 2 more ... CTD PMID:18550172 HSPA9 Human 2,6-di-tert-butyl-4-methylphenol increases expression ISO Hspa9 (Mus musculus) 6480464 Butylated Hydroxytoluene results in increased expression of HSPA9 mRNA CTD PMID:19925653 HSPA9 Human 2-hydroxypropanoic acid increases expression EXP 6480464 Lactic Acid results in increased expression of HSPA9 mRNA CTD PMID:30851411 HSPA9 Human 2-nitrofluorene increases expression ISO Hspa9 (Rattus norvegicus) 6480464 2-nitrofluorene results in increased expression of HSPA9 mRNA CTD PMID:15890375 HSPA9 Human 26-hydroxycholesterol increases expression EXP 6480464 27-hydroxycholesterol results in increased expression of HSPA9 protein CTD PMID:33880675 HSPA9 Human 26-hydroxycholesterol multiple interactions EXP 6480464 CAT protein inhibits the reaction [27-hydroxycholesterol results in increased expression of HSPA9 protein] more ... CTD PMID:33880675 HSPA9 Human 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Hspa9 (Mus musculus) 6480464 3 more ... CTD PMID:19467301 HSPA9 Human 3-chloropropane-1,2-diol decreases expression ISO Hspa9 (Rattus norvegicus) 6480464 alpha-Chlorohydrin analog results in decreased expression of HSPA9 protein and alpha-Chlorohydrin results in decreased expression of HSPA9 protein CTD PMID:26597043 HSPA9 Human 3-chloropropane-1,2-diol increases expression ISO Hspa9 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in increased expression of HSPA9 protein CTD PMID:26072098 HSPA9 Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HSPA9 mRNA CTD PMID:28628672 HSPA9 Human 3-nitropropanoic acid increases expression ISO Hspa9 (Rattus norvegicus) 6480464 3-nitropropionic acid results in increased expression of HSPA9 protein CTD PMID:37116597 HSPA9 Human 3H-1,2-dithiole-3-thione decreases expression ISO Hspa9 (Rattus norvegicus) 6480464 1 and 2-dithiol-3-thione results in decreased expression of HSPA9 mRNA CTD PMID:19162173 HSPA9 Human 4,4'-diaminodiphenylmethane affects expression ISO Hspa9 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane affects the expression of HSPA9 mRNA CTD PMID:18648102 HSPA9 Human 4,4'-sulfonyldiphenol multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HSPA9 mRNA CTD PMID:36041667 HSPA9 Human 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of HSPA9 protein CTD PMID:34186270 HSPA9 Human 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO Hspa9 (Rattus norvegicus) 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HSPA9 mRNA CTD PMID:15890375 HSPA9 Human 4-hydroxynon-2-enal affects binding EXP 6480464 4-hydroxy-2-nonenal analog binds to HSPA9 CTD PMID:18232660 HSPA9 Human 5-aza-2'-deoxycytidine increases response to substance EXP 6480464 HSPA9 protein results in increased susceptibility to Decitabine CTD PMID:17389721 HSPA9 Human 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of HSPA9 protein CTD PMID:19294695 HSPA9 Human 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 HSPA9 protein promotes the reaction [Decitabine results in increased expression of CDKN2A protein] CTD PMID:17389721 HSPA9 Human 6-propyl-2-thiouracil increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of HSPA9 mRNA CTD PMID:22504374 and PMID:30047161 HSPA9 Human 7H-xanthine multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of HSPA9 protein CTD PMID:19464573 HSPA9 Human 9H-xanthine multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 [Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of HSPA9 protein CTD PMID:19464573 HSPA9 Human acetamide decreases expression ISO Hspa9 (Rattus norvegicus) 6480464 acetamide results in decreased expression of HSPA9 mRNA CTD PMID:31881176 HSPA9 Human acetylleucyl-leucyl-norleucinal multiple interactions ISO Hspa9 (Mus musculus) 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [Acrylamide results in decreased expression of HSPA9 protein] CTD PMID:37353096 HSPA9 Human acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HSPA9 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of HSPA9 mRNA CTD PMID:32699268 HSPA9 Human acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of HSPA9 mRNA CTD PMID:32763439 HSPA9 Human acrylamide decreases expression ISO Hspa9 (Mus musculus) 6480464 Acrylamide results in decreased expression of HSPA9 protein CTD PMID:37353096 HSPA9 Human acrylamide multiple interactions ISO Hspa9 (Mus musculus) 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [Acrylamide results in decreased expression of HSPA9 protein] and benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Acrylamide results in decreased expression of HSPA9 protein] CTD PMID:37353096 HSPA9 Human actinomycin D multiple interactions EXP 6480464 [Dactinomycin co-treated with nutlin 3] results in increased secretion of HSPA9 protein CTD PMID:38460933 HSPA9 Human aflatoxin B1 increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of HSPA9 mRNA CTD PMID:15890375 HSPA9 Human aldehydo-D-glucose multiple interactions EXP 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of HSPA9 protein] CTD PMID:24218232 HSPA9 Human aldehydo-D-glucose multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA9 protein] CTD PMID:22413817 HSPA9 Human aldehydo-D-glucose decreases expression ISO Hspa9 (Rattus norvegicus) 6480464 Glucose results in decreased expression of HSPA9 protein CTD PMID:22413817 HSPA9 Human aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of HSPA9 protein CTD PMID:24218232 HSPA9 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of HSPA9 mRNA CTD PMID:33167477 HSPA9 Human alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HSPA9 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of HSPA9 mRNA CTD PMID:32699268 HSPA9 Human amitrole increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Amitrole results in increased expression of HSPA9 mRNA CTD PMID:30047161 HSPA9 Human ammonium chloride affects expression ISO Hspa9 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of HSPA9 mRNA CTD PMID:16483693 HSPA9 Human ammonium chloride increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Ammonium Chloride results in increased expression of HSPA9 mRNA CTD PMID:12420312 HSPA9 Human anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 [sodium arsenite co-treated with pyrazolanthrone] promotes the reaction [HSPA9 protein binds to TP53 protein modified form] CTD PMID:22706169 HSPA9 Human aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of HSPA9 mRNA CTD PMID:33212167 HSPA9 Human Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of HSPA9 mRNA CTD PMID:17851650 HSPA9 Human Aroclor 1254 decreases expression ISO Hspa9 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of HSPA9 mRNA CTD PMID:23650126 HSPA9 Human arsane increases expression EXP 6480464 Arsenic results in increased expression of HSPA9 protein CTD PMID:19818359 HSPA9 Human arsane affects expression EXP 6480464 Arsenic affects the expression of HSPA9 mRNA CTD PMID:18414638 HSPA9 Human arsenic atom affects expression EXP 6480464 Arsenic affects the expression of HSPA9 mRNA CTD PMID:18414638 HSPA9 Human arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of HSPA9 protein CTD PMID:19818359 HSPA9 Human arsenite(3-) multiple interactions EXP 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [arsenite results in increased expression of HSPA9 mRNA] more ... CTD PMID:20199942 HSPA9 Human arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of HSPA9 mRNA and arsenite results in increased expression of HSPA9 protein CTD PMID:20199942 HSPA9 Human arsenous acid increases expression ISO Hspa9 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of HSPA9 protein CTD PMID:27638049 HSPA9 Human arsenous acid multiple interactions ISO Hspa9 (Mus musculus) 6480464 ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of HSPA9 protein] CTD PMID:27638049 HSPA9 Human atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of HSPA9 mRNA CTD PMID:22378314 HSPA9 Human benzo[a]pyrene multiple interactions ISO Hspa9 (Mus musculus) 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of HSPA9 mRNA] CTD PMID:22228805 HSPA9 Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of HSPA9 promoter CTD PMID:27901495 HSPA9 Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of HSPA9 mRNA CTD PMID:38218311 HSPA9 Human bexarotene increases expression ISO Hspa9 (Rattus norvegicus) 6480464 bexarotene results in increased expression of HSPA9 mRNA CTD PMID:16648578 HSPA9 Human bis(2-ethylhexyl) phthalate increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in increased expression of HSPA9 mRNA CTD PMID:21318169 HSPA9 Human bisphenol A increases expression ISO Hspa9 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of HSPA9 mRNA CTD PMID:25181051 HSPA9 Human bisphenol A multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HSPA9 mRNA CTD PMID:36041667 HSPA9 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HSPA9 protein CTD PMID:31675489 and PMID:34186270 HSPA9 Human bisphenol A decreases expression ISO Hspa9 (Mus musculus) 6480464 bisphenol A results in decreased expression of HSPA9 mRNA CTD PMID:33221593 HSPA9 Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of HSPA9 mRNA CTD PMID:33670352 HSPA9 Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of HSPA9 mRNA CTD PMID:30903817 HSPA9 Human bisphenol A multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HSPA9 mRNA CTD PMID:28628672 HSPA9 Human Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of HSPA9 protein CTD PMID:34186270 HSPA9 Human bisphenol F multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HSPA9 mRNA CTD PMID:36041667 HSPA9 Human Brodifacoum increases expression ISO Hspa9 (Rattus norvegicus) 6480464 bromfenacoum results in increased expression of HSPA9 protein CTD PMID:28903499 HSPA9 Human cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSPA9 protein CTD PMID:33040242 HSPA9 Human cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSPA9 protein CTD PMID:33040242 HSPA9 Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of HSPA9 protein CTD PMID:24527689 HSPA9 Human cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of HSPA9 mRNA CTD PMID:23828170 HSPA9 Human caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of HSPA9 protein CTD PMID:31195006 HSPA9 Human calcium atom increases abundance ISO Hspa9 (Rattus norvegicus) 6480464 HSPA9 protein results in increased abundance of Calcium CTD PMID:34308505 HSPA9 Human calcium(0) increases abundance ISO Hspa9 (Rattus norvegicus) 6480464 HSPA9 protein results in increased abundance of Calcium CTD PMID:34308505 HSPA9 Human carbon nanotube increases expression ISO Hspa9 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of HSPA9 mRNA CTD PMID:25554681 HSPA9 Human casticin decreases expression ISO Hspa9 (Mus musculus) 6480464 casticin results in decreased expression of HSPA9 mRNA CTD PMID:28444820 HSPA9 Human chloropicrin affects expression EXP 6480464 chloropicrin affects the expression of HSPA9 mRNA CTD PMID:26352163 HSPA9 Human chloroprene increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Chloroprene results in increased expression of HSPA9 mRNA CTD PMID:23125180 HSPA9 Human chlorpyrifos decreases expression ISO Hspa9 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of HSPA9 mRNA CTD PMID:37019170 HSPA9 Human chromium(6+) affects expression ISO Hspa9 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of HSPA9 mRNA CTD PMID:28472532 HSPA9 Human cisplatin decreases response to substance EXP 6480464 HSPA9 protein results in decreased susceptibility to Cisplatin CTD PMID:21496427 HSPA9 Human clofibrate increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Clofibrate results in increased expression of HSPA9 protein CTD PMID:16470657 HSPA9 Human clofibrate increases expression ISO Hspa9 (Mus musculus) 6480464 Clofibrate results in increased expression of HSPA9 mRNA CTD PMID:23811191 HSPA9 Human clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of HSPA9 protein CTD PMID:34122009 HSPA9 Human cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of HSPA9 mRNA CTD PMID:19320972 HSPA9 Human cobalt dichloride increases expression ISO Hspa9 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of HSPA9 mRNA CTD PMID:24386269 HSPA9 Human cocaine multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 Anisomycin inhibits the reaction [Cocaine results in increased expression of HSPA9 protein] CTD PMID:12422371 HSPA9 Human cocaine increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Cocaine results in increased expression of HSPA9 protein CTD PMID:12422371 HSPA9 Human copper atom multiple interactions ISO Hspa9 (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of HSPA9 mRNA CTD PMID:15467011 HSPA9 Human copper(0) multiple interactions ISO Hspa9 (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of HSPA9 mRNA CTD PMID:15467011 HSPA9 Human copper(II) chloride decreases expression ISO Hspa9 (Mus musculus) 6480464 cupric chloride results in decreased expression of HSPA9 protein CTD PMID:29617964 HSPA9 Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of HSPA9 mRNA CTD PMID:19549813 HSPA9 Human coumestrol increases expression EXP 6480464 Coumestrol results in increased expression of HSPA9 mRNA CTD PMID:19167446 HSPA9 Human CU-O LINKAGE decreases expression EXP 6480464 cupric oxide results in decreased expression of HSPA9 protein CTD PMID:25470785 HSPA9 Human cyclophosphamide decreases expression ISO Hspa9 (Rattus norvegicus) 6480464 Cyclophosphamide results in decreased expression of HSPA9 mRNA CTD PMID:11906922 HSPA9 Human cyclosporin A multiple interactions EXP 6480464 [Cyclosporine co-treated with Cholic Acids] affects the expression of HSPA9 mRNA CTD PMID:27344345 HSPA9 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of HSPA9 mRNA CTD PMID:20106945 more ... HSPA9 Human cylindrospermopsin decreases expression EXP 6480464 cylindrospermopsin results in decreased expression of HSPA9 protein CTD PMID:27494769 HSPA9 Human D-glucose multiple interactions EXP 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of HSPA9 protein] CTD PMID:24218232 HSPA9 Human D-glucose multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA9 protein] CTD PMID:22413817 HSPA9 Human D-glucose decreases expression ISO Hspa9 (Rattus norvegicus) 6480464 Glucose results in decreased expression of HSPA9 protein CTD PMID:22413817 HSPA9 Human D-glucose increases expression EXP 6480464 Glucose results in increased expression of HSPA9 protein CTD PMID:24218232 HSPA9 Human decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of HSPA9 protein CTD PMID:31675489 HSPA9 Human desferrioxamine B multiple interactions EXP 6480464 [Deferoxamine results in decreased abundance of Iron] which results in decreased expression of HSPA9 mRNA CTD PMID:12393473 HSPA9 Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HSPA9 mRNA CTD PMID:28628672 HSPA9 Human diallyl trisulfide decreases expression EXP 6480464 diallyl trisulfide results in decreased expression of HSPA9 protein CTD PMID:19550292 HSPA9 Human diarsenic trioxide multiple interactions ISO Hspa9 (Mus musculus) 6480464 ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of HSPA9 protein] CTD PMID:27638049 HSPA9 Human diarsenic trioxide increases expression ISO Hspa9 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of HSPA9 protein CTD PMID:27638049 HSPA9 Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of HSPA9 mRNA CTD PMID:37042841 HSPA9 Human dibutyl phthalate increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in increased expression of HSPA9 mRNA CTD PMID:21266533 HSPA9 Human dieldrin affects expression ISO Hspa9 (Rattus norvegicus) 6480464 Dieldrin affects the expression of HSPA9 mRNA CTD PMID:22546817 HSPA9 Human diethylstilbestrol increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Diethylstilbestrol results in increased expression of HSPA9 mRNA CTD PMID:15890375 HSPA9 Human diethylstilbestrol increases expression ISO Hspa9 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of HSPA9 mRNA CTD PMID:21041162 HSPA9 Human dioxygen multiple interactions ISO Hspa9 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HSPA9 mRNA CTD PMID:30529165 HSPA9 Human disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of HSPA9 mRNA CTD PMID:18175754 HSPA9 Human dopamine increases expression EXP 6480464 Dopamine results in increased expression of HSPA9 protein CTD PMID:24675778 HSPA9 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 HSPA9 Human doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of HSPA9 mRNA CTD PMID:17680992 and PMID:29803840 HSPA9 Human efavirenz multiple interactions EXP 6480464 efavirenz promotes the reaction [VDAC1 protein binds to HSPA9 protein] CTD PMID:28940366 HSPA9 Human elemental selenium decreases expression EXP 6480464 Selenium results in decreased expression of HSPA9 mRNA CTD PMID:19244175 HSPA9 Human elemental selenium multiple interactions EXP 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of HSPA9 mRNA CTD PMID:19244175 HSPA9 Human endosulfan increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of HSPA9 mRNA CTD PMID:29391264 HSPA9 Human entinostat increases expression EXP 6480464 entinostat results in increased expression of HSPA9 mRNA CTD PMID:26272509 HSPA9 Human entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA9 mRNA CTD PMID:27188386 HSPA9 Human enzyme inhibitor multiple interactions EXP 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HSPA9 protein CTD PMID:23301498 HSPA9 Human fenofibrate increases expression ISO Hspa9 (Mus musculus) 6480464 Fenofibrate results in increased expression of HSPA9 mRNA CTD PMID:21318169 HSPA9 Human fenofibrate multiple interactions ISO Hspa9 (Mus musculus) 6480464 PPARA protein affects the reaction [Fenofibrate results in increased expression of HSPA9 mRNA] CTD PMID:21318169 HSPA9 Human fenthion decreases expression ISO Hspa9 (Mus musculus) 6480464 Fenthion results in decreased expression of HSPA9 mRNA CTD PMID:34813904 HSPA9 Human ferric ammonium citrate multiple interactions EXP 6480464 [ferric ammonium citrate results in increased abundance of Iron] which results in increased expression of HSPA9 mRNA CTD PMID:12393473 HSPA9 Human finasteride increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Finasteride results in increased expression of HSPA9 mRNA CTD PMID:24136188 HSPA9 Human flufenoxuron increases expression ISO Hspa9 (Mus musculus) 6480464 flufenoxuron results in increased expression of HSPA9 protein CTD PMID:33771252 HSPA9 Human fluorescein 5-isothiocyanate affects binding EXP 6480464 Fluorescein-5-isothiocyanate binds to HSPA9 protein CTD PMID:27129696 HSPA9 Human flutamide increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Flutamide results in increased expression of HSPA9 mRNA CTD PMID:24136188 HSPA9 Human folic acid affects expression ISO Hspa9 (Rattus norvegicus) 6480464 Folic Acid affects the expression of HSPA9 protein CTD PMID:16251605 HSPA9 Human folic acid multiple interactions ISO Hspa9 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of HSPA9 mRNA] CTD PMID:22206623 HSPA9 Human FR900359 increases phosphorylation EXP 6480464 FR900359 results in increased phosphorylation of HSPA9 protein CTD PMID:37730182 HSPA9 Human gallium nitrate decreases expression EXP 6480464 gallium nitrate results in decreased expression of HSPA9 mRNA CTD PMID:18586083 HSPA9 Human genistein multiple interactions EXP 6480464 ESR2 promotes the reaction [Genistein results in increased expression of HSPA9 protein] CTD PMID:20884965 HSPA9 Human genistein increases expression EXP 6480464 Genistein results in increased expression of HSPA9 protein CTD PMID:20884965 HSPA9 Human gentamycin increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of HSPA9 mRNA CTD PMID:22061828 and PMID:33387578 HSPA9 Human glucose multiple interactions EXP 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of HSPA9 protein] CTD PMID:24218232 HSPA9 Human glucose decreases expression ISO Hspa9 (Rattus norvegicus) 6480464 Glucose results in decreased expression of HSPA9 protein CTD PMID:22413817 HSPA9 Human glucose multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA9 protein] CTD PMID:22413817 HSPA9 Human glucose increases expression EXP 6480464 Glucose results in increased expression of HSPA9 protein CTD PMID:24218232 HSPA9 Human gold atom multiple interactions ISO Hspa9 (Mus musculus) 6480464 [Gold co-treated with Polyethylene Glycols] results in increased expression of HSPA9 mRNA CTD PMID:19695318 HSPA9 Human gold(0) multiple interactions ISO Hspa9 (Mus musculus) 6480464 [Gold co-treated with Polyethylene Glycols] results in increased expression of HSPA9 mRNA CTD PMID:19695318 HSPA9 Human hemin multiple interactions EXP 6480464 [Hemin results in increased abundance of Iron] which results in increased expression of HSPA9 mRNA CTD PMID:12393473 HSPA9 Human homocysteine multiple interactions EXP 6480464 Homocysteine promotes the reaction [HSPA9 protein binds to ITPR1 protein] and Homocysteine promotes the reaction [HSPA9 protein binds to VDAC1 protein] CTD PMID:33751715 HSPA9 Human hydrazine increases expression ISO Hspa9 (Rattus norvegicus) 6480464 hydrazine results in increased expression of HSPA9 protein CTD PMID:15370871 HSPA9 Human indirubin-3'-monoxime multiple interactions EXP 6480464 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA9 mRNA CTD PMID:18958680 HSPA9 Human indirubin-3'-monoxime increases expression EXP 6480464 indirubin-3'-monoxime results in increased expression of HSPA9 mRNA CTD PMID:18958680 HSPA9 Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HSPA9 mRNA CTD PMID:28628672 HSPA9 Human iron atom multiple interactions EXP 6480464 [Deferoxamine results in decreased abundance of Iron] which results in decreased expression of HSPA9 mRNA more ... CTD PMID:12393473 HSPA9 Human iron(0) multiple interactions EXP 6480464 [Deferoxamine results in decreased abundance of Iron] which results in decreased expression of HSPA9 mRNA more ... CTD PMID:12393473 HSPA9 Human isotretinoin decreases expression EXP 6480464 Isotretinoin results in decreased expression of HSPA9 mRNA CTD PMID:20436886 HSPA9 Human ivermectin increases expression EXP 6480464 Ivermectin results in increased expression of HSPA9 mRNA CTD PMID:28942281 HSPA9 Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of HSPA9 protein CTD PMID:32959892 HSPA9 Human ivermectin increases expression ISO Hspa9 (Mus musculus) 6480464 Ivermectin results in increased expression of HSPA9 mRNA CTD PMID:28942281 HSPA9 Human L-ascorbic acid decreases expression EXP 6480464 Ascorbic Acid results in decreased expression of HSPA9 mRNA CTD PMID:19197388 HSPA9 Human lead diacetate increases expression ISO Hspa9 (Rattus norvegicus) 6480464 lead acetate results in increased expression of HSPA9 mRNA CTD PMID:11578147 HSPA9 Human lead nitrate multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 Ashwagandha inhibits the reaction [lead nitrate results in increased expression of HSPA9 mRNA] and Ashwagandha inhibits the reaction [lead nitrate results in increased expression of HSPA9 protein] CTD PMID:24987671 HSPA9 Human lead nitrate increases expression ISO Hspa9 (Rattus norvegicus) 6480464 lead nitrate results in increased expression of HSPA9 mRNA and lead nitrate results in increased expression of HSPA9 protein CTD PMID:24987671 HSPA9 Human lead(II) chloride decreases expression EXP 6480464 lead chloride results in decreased expression of HSPA9 protein CTD PMID:24419708 HSPA9 Human lithium atom multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of HSPA9 mRNA] CTD PMID:19149911 HSPA9 Human lithium atom increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Lithium results in increased expression of HSPA9 protein CTD PMID:18296634 HSPA9 Human lithium hydride multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of HSPA9 mRNA] CTD PMID:19149911 HSPA9 Human lithium hydride increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Lithium results in increased expression of HSPA9 protein CTD PMID:18296634 HSPA9 Human melatonin multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 Melatonin affects the reaction [Mercuric Chloride results in increased expression of HSPA9 protein] CTD PMID:16801527 HSPA9 Human mercury dichloride multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 [Mercuric Chloride co-treated with bimoclomol] affects the localization of HSPA9 protein and Melatonin affects the reaction [Mercuric Chloride results in increased expression of HSPA9 protein] CTD PMID:16801527 and PMID:16891066 HSPA9 Human mercury dichloride increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Mercuric Chloride results in increased expression of HSPA9 protein CTD PMID:15375764 more ... HSPA9 Human metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [INS protein results in decreased expression of HSPA9 protein] CTD PMID:36764371 HSPA9 Human methamphetamine multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of HSPA9 mRNA] and Valproic Acid inhibits the reaction [Methamphetamine results in increased expression of HSPA9 mRNA] CTD PMID:19149911 HSPA9 Human methamphetamine increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Methamphetamine results in increased expression of HSPA9 mRNA CTD PMID:19149911 HSPA9 Human methapyrilene increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Methapyrilene results in increased expression of HSPA9 mRNA CTD PMID:15890375 more ... HSPA9 Human methapyrilene decreases expression ISO Hspa9 (Rattus norvegicus) 6480464 Methapyrilene results in decreased expression of HSPA9 protein CTD PMID:30467583 HSPA9 Human methimazole increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Methimazole results in increased expression of HSPA9 mRNA CTD PMID:22504374 and PMID:30047161 HSPA9 Human methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of HSPA9 mRNA CTD PMID:28001369 HSPA9 Human methylmercury chloride increases expression ISO Hspa9 (Mus musculus) 6480464 methylmercuric chloride results in increased expression of HSPA9 mRNA and methylmercuric chloride results in increased expression of HSPA9 protein CTD PMID:37967789 HSPA9 Human methylmercury chloride multiple interactions ISO Hspa9 (Mus musculus) 6480464 ATF4 protein promotes the reaction [methylmercuric chloride results in increased expression of HSPA9 protein] and DDIT3 protein promotes the reaction [methylmercuric chloride results in increased expression of HSPA9 protein] CTD PMID:37967789 HSPA9 Human methylparaben increases expression EXP 6480464 methylparaben results in increased expression of HSPA9 mRNA CTD PMID:31745603 HSPA9 Human mevinphos increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Mevinphos results in increased expression of HSPA9 protein CTD PMID:17150954 HSPA9 Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO Hspa9 (Mus musculus) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Acrylamide results in decreased expression of HSPA9 protein] CTD PMID:37353096 HSPA9 Human N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of HSPA9 mRNA] CTD PMID:12710931 HSPA9 Human N-methyl-4-phenylpyridinium increases expression ISO Hspa9 (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of HSPA9 mRNA CTD PMID:28801915 HSPA9 Human N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of HSPA9 protein CTD PMID:24675778 HSPA9 Human N-nitrosodimethylamine increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Dimethylnitrosamine results in increased expression of HSPA9 mRNA CTD PMID:15890375 HSPA9 Human N-nitrosomorpholine increases expression ISO Hspa9 (Rattus norvegicus) 6480464 N-nitrosomorpholine results in increased expression of HSPA9 protein CTD PMID:19716841 HSPA9 Human nefazodone increases expression ISO Hspa9 (Rattus norvegicus) 6480464 nefazodone results in increased expression of HSPA9 mRNA CTD PMID:24136188 HSPA9 Human nickel dichloride affects expression ISO Hspa9 (Rattus norvegicus) 6480464 nickel chloride affects the expression of HSPA9 mRNA CTD PMID:22546817 HSPA9 Human Nutlin-3 multiple interactions EXP 6480464 [Dactinomycin co-treated with nutlin 3] results in increased secretion of HSPA9 protein CTD PMID:38460933 HSPA9 Human ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of HSPA9 mRNA and ochratoxin A results in decreased expression of HSPA9 protein CTD PMID:19051279 and PMID:31369848 HSPA9 Human ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of HSPA9 protein CTD PMID:31369848 HSPA9 Human ochratoxin A multiple interactions EXP 6480464 HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of HAVCR1 protein] and HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of LONP1 protein] CTD PMID:31369848 HSPA9 Human ochratoxin A increases expression ISO Hspa9 (Rattus norvegicus) 6480464 ochratoxin A results in increased expression of HSPA9 protein CTD PMID:31369848 HSPA9 Human ochratoxin A multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 HSPA9 protein affects the reaction [ochratoxin A results in decreased expression of LONP1 protein] and HSPA9 protein affects the reaction [ochratoxin A results in increased expression of HAVCR1 protein] CTD PMID:31369848 HSPA9 Human ochratoxin A decreases expression ISO Hspa9 (Rattus norvegicus) 6480464 ochratoxin A results in decreased expression of HSPA9 protein CTD PMID:31369848 HSPA9 Human ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HSPA9 mRNA more ... CTD PMID:32699268 HSPA9 Human paracetamol affects expression ISO Hspa9 (Mus musculus) 6480464 Acetaminophen affects the expression of HSPA9 mRNA CTD PMID:17562736 HSPA9 Human paracetamol multiple interactions ISO Hspa9 (Mus musculus) 6480464 [CTH gene mutant form results in increased susceptibility to Acetaminophen] which results in increased expression of HSPA9 protein CTD PMID:25499718 HSPA9 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of HSPA9 mRNA CTD PMID:25704631 HSPA9 Human paracetamol increases expression ISO Hspa9 (Mus musculus) 6480464 Acetaminophen results in increased expression of HSPA9 protein CTD PMID:11752693 HSPA9 Human paraquat increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Paraquat results in increased expression of HSPA9 mRNA CTD PMID:17935786 and PMID:32680482 HSPA9 Human perfluorododecanoic acid increases expression ISO Hspa9 (Rattus norvegicus) 6480464 perfluorododecanoic acid results in increased expression of HSPA9 protein CTD PMID:26168851 HSPA9 Human perfluorooctane-1-sulfonic acid affects expression ISO Hspa9 (Mus musculus) 6480464 perfluorooctane sulfonic acid affects the expression of HSPA9 mRNA CTD PMID:19429403 HSPA9 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Hspa9 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HSPA9 mRNA and perfluorooctane sulfonic acid inhibits the reaction [ITPR1 protein binds to HSPA9 protein binds to VDAC1 protein] CTD PMID:28288859 and PMID:36331819 HSPA9 Human perfluorooctanoic acid affects expression ISO Hspa9 (Mus musculus) 6480464 perfluorooctanoic acid affects the expression of HSPA9 mRNA CTD PMID:19429403 HSPA9 Human perfluorooctanoic acid increases expression ISO Hspa9 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in increased expression of HSPA9 mRNA CTD PMID:19162173 and PMID:21318169 HSPA9 Human phlorizin decreases expression ISO Hspa9 (Mus musculus) 6480464 Phlorhizin results in decreased expression of HSPA9 mRNA CTD PMID:22538082 HSPA9 Human phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA9 mRNA CTD PMID:18958680 HSPA9 Human phosgene affects expression ISO Hspa9 (Mus musculus) 6480464 Phosgene affects the expression of HSPA9 mRNA CTD PMID:16300373 HSPA9 Human piperonyl butoxide increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Piperonyl Butoxide results in increased expression of HSPA9 mRNA CTD PMID:15890375 HSPA9 Human pirinixic acid increases expression ISO Hspa9 (Mus musculus) 6480464 pirinixic acid results in increased expression of HSPA9 mRNA CTD PMID:21318169 HSPA9 Human pirinixic acid increases expression ISO Hspa9 (Rattus norvegicus) 6480464 pirinixic acid results in increased expression of HSPA9 mRNA CTD PMID:15890375 more ... HSPA9 Human pirinixic acid multiple interactions ISO Hspa9 (Mus musculus) 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of HSPA9 mRNA] CTD PMID:21318169 HSPA9 Human piroxicam decreases expression EXP 6480464 Piroxicam results in decreased expression of HSPA9 mRNA CTD PMID:21858171 HSPA9 Human potassium dichromate increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Potassium Dichromate results in increased expression of HSPA9 protein CTD PMID:18563748 HSPA9 Human pterostilbene increases expression EXP 6480464 pterostilbene results in increased expression of HSPA9 mRNA CTD PMID:22450950 HSPA9 Human rac-lactic acid increases expression EXP 6480464 Lactic Acid results in increased expression of HSPA9 mRNA CTD PMID:30851411 HSPA9 Human resveratrol multiple interactions EXP 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of HSPA9 mRNA and Resveratrol inhibits the reaction [Glucose results in increased expression of HSPA9 protein] CTD PMID:23557933 and PMID:24218232 HSPA9 Human resveratrol increases expression ISO Hspa9 (Mus musculus) 6480464 resveratrol results in increased expression of HSPA9 protein CTD PMID:25505154 HSPA9 Human rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of HSPA9 protein CTD PMID:16565515 HSPA9 Human rotenone increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Rotenone results in increased expression of HSPA9 protein CTD PMID:35544339 HSPA9 Human rotenone increases expression ISO Hspa9 (Mus musculus) 6480464 Rotenone results in increased expression of HSPA9 mRNA CTD PMID:23186747 HSPA9 Human sarin affects expression ISO Hspa9 (Rattus norvegicus) 6480464 Sarin affects the expression of HSPA9 protein CTD PMID:28973502 HSPA9 Human SB 431542 multiple interactions EXP 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 HSPA9 Human selenium atom decreases expression EXP 6480464 Selenium results in decreased expression of HSPA9 mRNA CTD PMID:19244175 HSPA9 Human selenium atom multiple interactions EXP 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of HSPA9 mRNA CTD PMID:19244175 HSPA9 Human sodium arsenite decreases expression ISO Hspa9 (Rattus norvegicus) 6480464 sodium arsenite results in decreased expression of HSPA9 mRNA CTD PMID:19072884 HSPA9 Human sodium arsenite multiple interactions EXP 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [sodium arsenite results in increased expression of HSPA9 protein] more ... CTD PMID:20375080 and PMID:22706169 HSPA9 Human sodium arsenite increases expression ISO Hspa9 (Mus musculus) 6480464 sodium arsenite results in increased expression of HSPA9 mRNA CTD PMID:16014739 HSPA9 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of HSPA9 mRNA and sodium arsenite results in increased expression of HSPA9 protein CTD PMID:20375080 more ... HSPA9 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of HSPA9 mRNA and sodium arsenite results in decreased expression of HSPA9 protein CTD PMID:22706169 more ... HSPA9 Human sodium dichromate increases expression ISO Hspa9 (Rattus norvegicus) 6480464 sodium bichromate results in increased expression of HSPA9 mRNA CTD PMID:12325037 HSPA9 Human sodium fluoride increases expression ISO Hspa9 (Mus musculus) 6480464 Sodium Fluoride results in increased expression of HSPA9 protein CTD PMID:27548804 HSPA9 Human sodium fluoride decreases expression ISO Hspa9 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of HSPA9 protein CTD PMID:27548804 HSPA9 Human Soman increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Soman results in increased expression of HSPA9 mRNA CTD PMID:19281266 HSPA9 Human streptozocin decreases expression ISO Hspa9 (Rattus norvegicus) 6480464 Streptozocin results in decreased expression of HSPA9 protein CTD PMID:19634143 HSPA9 Human streptozocin multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 Trientine inhibits the reaction [Streptozocin results in decreased expression of HSPA9 protein] CTD PMID:19634143 HSPA9 Human sulfadimethoxine increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Sulfadimethoxine results in increased expression of HSPA9 mRNA CTD PMID:30047161 HSPA9 Human sulforaphane affects binding EXP 6480464 HSPA9 protein binds to sulforaphane CTD PMID:21838287 HSPA9 Human sulindac increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Sulindac results in increased expression of HSPA9 mRNA CTD PMID:24136188 HSPA9 Human sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of HSPA9 mRNA CTD PMID:31533062 HSPA9 Human T-2 toxin affects expression ISO Hspa9 (Rattus norvegicus) 6480464 T-2 Toxin affects the expression of HSPA9 protein CTD PMID:26141394 HSPA9 Human testosterone decreases expression ISO Hspa9 (Mus musculus) 6480464 Testosterone results in decreased expression of HSPA9 mRNA CTD PMID:21669218 HSPA9 Human tetrachloroethene increases expression ISO Hspa9 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of HSPA9 mRNA CTD PMID:28973375 HSPA9 Human tetrachloromethane multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA9 mRNA] CTD PMID:31150632 HSPA9 Human tetrachloromethane increases expression ISO Hspa9 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of HSPA9 mRNA CTD PMID:30538632 HSPA9 Human tetrachloromethane increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of HSPA9 mRNA CTD PMID:31150632 HSPA9 Human thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of HSPA9 protein CTD PMID:21692457 HSPA9 Human thapsigargin increases expression ISO Hspa9 (Mus musculus) 6480464 Thapsigargin results in increased expression of HSPA9 mRNA CTD PMID:28942281 HSPA9 Human thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of HSPA9 mRNA CTD PMID:22378314 HSPA9 Human thiram increases expression EXP 6480464 Thiram results in increased expression of HSPA9 mRNA CTD PMID:38568856 HSPA9 Human titanium dioxide decreases methylation ISO Hspa9 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of HSPA9 gene CTD PMID:35295148 HSPA9 Human trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of HSPA9 protein CTD PMID:19294695 HSPA9 Human trimellitic anhydride increases expression ISO Hspa9 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of HSPA9 mRNA CTD PMID:19042947 HSPA9 Human troglitazone increases expression ISO Hspa9 (Mus musculus) 6480464 troglitazone results in increased expression of HSPA9 protein CTD PMID:18495193 HSPA9 Human tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of HSPA9 mRNA CTD PMID:22378314 HSPA9 Human tunicamycin increases expression ISO Hspa9 (Mus musculus) 6480464 Tunicamycin results in increased expression of HSPA9 mRNA CTD PMID:28942281 HSPA9 Human urethane decreases expression EXP 6480464 Urethane results in decreased expression of HSPA9 mRNA CTD PMID:28818685 HSPA9 Human valproic acid multiple interactions ISO Hspa9 (Rattus norvegicus) 6480464 Valproic Acid inhibits the reaction [Methamphetamine results in increased expression of HSPA9 mRNA] CTD PMID:19149911 HSPA9 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA9 mRNA CTD PMID:27188386 HSPA9 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of HSPA9 mRNA CTD PMID:23179753 more ... HSPA9 Human valproic acid increases expression ISO Hspa9 (Rattus norvegicus) 6480464 Valproic Acid results in increased expression of HSPA9 mRNA CTD PMID:21318169 HSPA9 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of HSPA9 mRNA CTD PMID:25979313 HSPA9 Human vanillic acid multiple interactions EXP 6480464 Vanillic Acid inhibits the reaction [INS protein results in decreased expression of HSPA9 protein] CTD PMID:36764371 HSPA9 Human vinclozolin increases expression ISO Hspa9 (Rattus norvegicus) 6480464 vinclozolin results in increased expression of HSPA9 mRNA CTD PMID:23034163 HSPA9 Human vitamin E decreases expression EXP 6480464 Vitamin E results in decreased expression of HSPA9 mRNA CTD PMID:19244175 HSPA9 Human vitamin E multiple interactions EXP 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of HSPA9 mRNA CTD PMID:19244175 HSPA9 Human vorinostat decreases expression EXP 6480464 vorinostat results in decreased expression of HSPA9 protein CTD PMID:20543569 HSPA9 Human withaferin A affects binding EXP 6480464 withaferin A binds to HSPA9 protein CTD PMID:22973447 HSPA9 Human withaferin A multiple interactions EXP 6480464 [withaferin A inhibits the reaction [HSPA9 protein binds to TP53 protein]] which affects the localization of and results in increased activity of TP53 protein more ... CTD PMID:22973447 and PMID:25236891 HSPA9 Human Withanone multiple interactions EXP 6480464 [withanone co-treated with withaferin A] results in decreased expression of HSPA9 protein more ... CTD PMID:22155302 and PMID:25236891
